SCHEMBL20157947

SCHEMBL20157947

CCOC(=O)OC(C)OC(O)CCCN(Cc1ccccc1)c1cc(C(F)(F)F)ccc1C=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
DHFR P00374 2/20 0.34
CETP P11597 5/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 2/20 0.32
POLB P06746 1/20 0.32
HSD17B10 Q99714 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
USP2 O75604 2/20 0.32
CYP3A4 P08684 2/20 0.32
NR1I2 O75469 1/20 0.32
ADRB1 P08588 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
ADORA3 P0DMS8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20137060 0.87 MGLL (0.41) PPARGPPARDPPARADHFRCETP
SCHEMBL20157948 0.82 CETP (0.36) PPARGPPARDPPARACETPNR1H2
SCHEMBL20179985 0.81 PPARG (0.38) PPARGPPARDPPARADHFRCETP
SCHEMBL20158307 0.80 CETP (0.40) PPARGPPARDPPARACETPNR1H2
SCHEMBL20166820 0.79 ALOX5 (0.40) PPARGPPARDPPARADHFRCETP
SCHEMBL20137125 0.78 MGLL (0.39) PPARGPPARDPPARADHFRCETP
SCHEMBL20151844 0.76 ALOX5 (0.37) PPARGPPARDPPARAALDH1A1KDM4E
SCHEMBL20137089 0.75 FFAR4 (0.39) PPARGPPARDPPARACETPNR1H2
SCHEMBL29561187 0.75 FFAR4 (0.39) PPARGPPARDPPARACETPNR1H2
SCHEMBL20166910 0.75 KDM4E (0.39) PPARGPPARDPPARACETPNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134674-A1 MAGL INHIBITORS H. LUNDBECK A/S (DK) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134674-A1 MAGL INHIBITORS MAG, MAGI3, MGLL PPARG 2047/4885PPARD 2641/4885PPARA 2252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.